Human placental lactogen (hPL) model for the normal pregnancy

Area of Science:

• Reproductive Endocrinology
• Maternal-Fetal Medicine
• Biomathematics

Background:

• Human placental lactogen (hPL) is a key hormone in pregnancy.
• Accurate hPL monitoring aids in assessing fetal well-being.
• Predictive models for hPL are crucial for early detection of pregnancy complications.

Purpose of the Study:

• To define a modified Gompertz equation for longitudinal hPL level tracking.
• To establish an early forecasting model for hPL in normal pregnancies.
• To evaluate the model's applicability in pathological pregnancies.

Main Methods:

• Longitudinal sampling of hPL levels from gestational week 26 to labor in 75 normal pregnancies.
• Development and fitting of a modified Gompertz equation to individual hPL data.
• Validation of the model using maternal height, age, and a single hPL sample for forecasting.

Main Results:

• The modified Gompertz equation accurately fitted individual hPL series, showing a plateau by gestational week 36.
• A reliable hPL forecast for normal pregnancy was achievable by gestational week 30.
• In six cases of intrauterine growth retardation, measured hPL levels were consistently below the model's estimates.

Conclusions:

• The modified Gompertz equation provides a robust framework for understanding hPL dynamics during pregnancy.
• Early hPL prediction is feasible, potentially improving the management of high-risk pregnancies.
• The model's underestimation in intrauterine growth retardation cases highlights its potential diagnostic value.